Cellular senescence bypass screen identifies new putative tumor suppressor genes

Senescence is a mechanism that limits cellular lifespan and constitutes a barrier against cellular immortalization. To identify new senescence regulatory genes that might play a role in tumorigenesis, we have designed and performed a large-scale antisense-based genetic screen in primary mouse embryo fibroblasts (MEFs). Out of this screen, we have identified five different genes through which loss of function partially bypasses senescence. These genes belong to very different biochemical families: csn2 (component of the Cop9 signalosome), aldose reductase (a metabolic enzyme) and brf1 (subunit of the RNA polymerase II complex), S-adenosyl homocysteine hydrolase and Bub1. Inactivation, at least partial, of these genes confers resistance to both p53- and p16INK4a-induced proliferation arrest. Furthermore, such inactivation inhibits p53 but not E2F1 transcriptional activity and impairs DNA-damage-induced transcription of p21. Since the aim of the screen was to identify new regulators of tumorigenesis, we have tested their inactivation in human tumors. We have found, either by northern blot or quantitative reverse transcriptase–PCR analysis, that the expression of three genes, Csn2, Aldose reductase and Brf1, is lost at different ratios in tumors of different origins. These genes are located at common positions of loss of heterogeneity (15q21.2, 7q35 and 14q32.33); therefore,we have measured genomic losses of these specific genes in different tumors. We have found that Csn2 and Brf1 also show genomic losses of one allele in different tumors. Our data suggest that the three genes identified in the genome-wide loss-of-function genetic screen are putative tumor suppressors located at 15q21.2; 7q35 and 14q32.33.

[1]  X. Deng,et al.  Disruption of the COP9 Signalosome Csn2 Subunit in Mice Causes Deficient Cell Proliferation, Accumulation of p53 and Cyclin E, and Early Embryonic Death , 2003, Molecular and Cellular Biology.

[2]  F. Rojo,et al.  New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. , 2006, Oncology reports.

[3]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[4]  T. Jacks,et al.  Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. , 2000, Genes & development.

[5]  Keiji Suzuki,et al.  Radiation-Induced Senescence-like Growth Arrest Requires TP53 Function but not Telomere Shortening , 2001, Radiation research.

[6]  H. Stein,et al.  Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.

[7]  R. Kraft,et al.  COP9 signalosome‐specific phosphorylation targets p53 to degradation by the ubiquitin system , 2001, The EMBO journal.

[8]  S. Jackson,et al.  Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein , 1997, The EMBO journal.

[9]  D. Beach,et al.  Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation , 2004, Oncogene.

[10]  Soyoung Lee,et al.  to the Outcome of Cancer Therapy , 2002 .

[11]  E. Blackburn,et al.  Tracking telomerase , 2004, Cell.

[12]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[13]  Reuven Agami,et al.  A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.

[14]  J. Campisi.  Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.

[15]  M. Seeger,et al.  The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. , 2002, Journal of cell science.

[16]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[17]  J. Shay,et al.  Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.

[18]  J. Kato,et al.  Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3 , 2005, The EMBO journal.

[19]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[20]  M. Blasco,et al.  Putting the stress on senescence. , 2001, Current opinion in cell biology.

[21]  M. White,et al.  Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.

[22]  S. Jackson,et al.  A Role for TAF3B2 in the Repression of Human RNA Polymerase III Transcription in Nonproliferating Cells* , 2001, The Journal of Biological Chemistry.

[23]  Minami Matsui,et al.  The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex , 1998, Current Biology.

[24]  T. Jacks,et al.  Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice , 1998, Nature Genetics.

[25]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[26]  J. Bertherat,et al.  Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[28]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Hannon,et al.  Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. , 2000, Nucleic acids research.

[30]  Xiping Wang,et al.  The COP9 Signalosome Inhibits p27kip1 Degradation and Impedes G1-S Phase Progression via Deneddylation of SCF Cul1 , 2002, Current Biology.

[31]  J. Campisi.  Suppressing Cancer: The Importance of Being Senescent , 2005, Science.